| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
critical why stopped: null → "Investigator left the institution" |
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
Enrollment reduced: 36 -> 0 participants |
| 2026-06-05 | NCT06973109 Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes |
Sponsor changed: Nitin Agarwal -> University of Pittsburgh |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06264609 | Precision Medicine Approach for Osteoporosis - Follow Up Study | Osteoporosis | Enrolling by Invitation |
| NCT05151484 | Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover | Age-Related Osteoporosis | Active, Not Recruiting |
| Phase 2 | |||
| NCT06016634 | Alendronate for Osteonecrosis in Adults With Sickle Cell Disease | Sickle Cell Disease | Recruiting |
| NCT07471880 | A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage… | Osteonecrosis | Active, Not Recruiting |
| NCT07216794 | Small Trial of Alendronate Impact on the Reservoir of HIV | HIV | Not Yet Recruiting |